Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.

BetterSleep reports show that poor sleep impacts relationships significantly, increasing conflict and reducing empa ...

Started by a founder who could not tolerate a traditional therapy, the national provider network connects patients with trained dentists and medical professionals and uses medical billing to help keep ...

Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea patients, as well as ...

During Down Syndrome Awareness Month, Joe DiMaggio Children's Hospital is celebrating its first successful implantation of an ...

URA, a health intelligence platform and maker of the world’s smallest smart ring, today announced the launch of SMART-BMI, its first clinical trial, in collaboration with UC San Diego Health, ...

A study published in JMIR showed that Oura Ring is an accurate women's health product as well, with the Ovulation Detection algorithm outperforming the calendar tracking method and detecting 96.4% of ...

Shoulder pain occurs at dawnThis is the story of an 85-year-old female patient.She had symptoms similar to so-called frozen ...

A new survey by Everyday Health found that people taking GLP-1 drugs for weight loss are widely satisfied, but a diagnosis of obesity reduces treatment satisfaction. Here’s what else the survey found ...

After having insomnia for as long as I can remember, I have never slept better.

For some adolescents with Down syndrome, neither surgery to remove the tonsils nor a CPAP machine provides a workable solution for obstructive sleep apnea.

A new paper from the Equality, Diversity and Inclusion Committee and the Early Career Network of the European Sleep Research Society warns that sleep health is becoming a growing public health ...